BNFC-Recommended Omeprazole Withdrawal Protocol
Understanding Omeprazole Withdrawal
The BNFC emphasises that omeprazole withdrawal should be managed systematically to prevent rebound hyperacidity. This condition occurs when stomach acid production increases beyond normal levels after stopping PPI therapy, potentially causing worse symptoms than originally experienced.
Gradual Dose Reduction Method
BNFC guidelines recommend reducing omeprazole doses gradually over 4-8 weeks. For patients on 20mg daily, consider reducing to 10mg daily for 2-3 weeks before stopping completely. Those on higher doses should reduce by 50% every 2 weeks until reaching the lowest effective dose.
Step-Down Therapy Options
The BNFC suggests considering H2 receptor antagonists like famotidine during withdrawal. EverydayMeds stocks famotidine tablets which can provide interim acid control whilst omeprazole is being discontinued. This approach helps bridge the transition period and manage rebound symptoms effectively.
Alternative PPI Options
If complete withdrawal proves difficult, switching between different PPIs may help. EverydayMeds offers lansoprazole 15mg capsules, pantoprazole 20mg tablets, and esomeprazole tablets as alternatives to omeprazole, allowing for flexible dose adjustments during withdrawal attempts.
Managing Withdrawal Symptoms
Common withdrawal symptoms include increased heartburn, indigestion, and acid regurgitation. The BNFC recommends monitoring symptoms closely and implementing lifestyle modifications including dietary changes, weight management, and avoiding trigger foods during the withdrawal period.
When to Seek Medical Review
The BNF advises medical review if withdrawal symptoms persist beyond 4 weeks or if severe symptoms develop. Some patients may require longer-term PPI therapy, and attempting withdrawal should always be done under appropriate medical supervision to ensure patient safety.
